Titan Pharmaceuticals Correlations

TTNP Stock

USD 4.19 0.54 14.79%

The correlation of Titan Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Titan Pharmaceuticals Correlation With Market

Average diversification

The correlation between Titan Pharmaceuticals and DJI is 0.1 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Titan Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Titan Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

To learn how to invest in Titan Stock, please use our How to Invest in Titan Pharmaceuticals guide.

Moving together with Titan Stock

0.62	AZN	AstraZeneca PLC ADR	Pair Corr
0.63	LLY	Eli Lilly	Pair Corr
0.62	DRMAW	Dermata Therapeutics	Pair Corr

Moving against Titan Stock

0.64	MRK	Merck Company	Pair Corr
0.54	ZURA	Zura Bio Limited	Pair Corr
0.53	VINC	Vincerx Pharma Earnings Call This Week	Pair Corr
0.5	GPCR	Structure Therapeutics	Pair Corr
0.45	IMMX	Immix Biopharma	Pair Corr
0.44	ELVN	Enliven Therapeutics	Pair Corr
0.42	MLTX	MoonLake Immunotherapeuti	Pair Corr
0.4	IMRX	Immuneering Corp	Pair Corr
0.38	CDIOW	Cardio Diagnostics	Pair Corr
0.36	ELEV	Elevation Oncology	Pair Corr
0.66	SCLX	Scilex Holding	Pair Corr
0.6	BIIB	Biogen Inc	Pair Corr
0.56	CGEM	Cullinan Oncology LLC	Pair Corr
0.53	PYXS	Pyxis Oncology	Pair Corr
0.51	AVTE	Aerovate Therapeutics	Pair Corr
0.5	ASMB	Assembly Biosciences Earnings Call This Week	Pair Corr
0.47	CRNX	Crinetics Pharmaceuticals	Pair Corr
0.39	PHIO	Phio Pharmaceuticals Corp Earnings Call This Week	Pair Corr
0.38	CNSP	Cns Pharmaceuticals Earnings Call This Week	Pair Corr
0.36	ATNF	180 Life Sciences	Pair Corr
0.33	CDIO	Cardio Diagnostics	Pair Corr
0.32	PMVP	Pmv Pharmaceuticals	Pair Corr

Related Correlations Analysis

	FWBI	SLRX	SABS	VCNX	GOVX	SNTI	ZIVO	CVKD	FHTX
FWBI		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	FWBI
SLRX	0.0		0.48	0.0	0.45	0.5	0.0	0.09	-0.27	SLRX
SABS	0.0	0.48		0.0	0.9	0.51	0.0	-0.59	-0.03	SABS
VCNX	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	VCNX
GOVX	0.0	0.45	0.9	0.0		0.47	0.0	-0.65	0.01	GOVX
SNTI	0.0	0.5	0.51	0.0	0.47		0.0	-0.2	0.18	SNTI
ZIVO	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	ZIVO
CVKD	0.0	0.09	-0.59	0.0	-0.65	-0.2	0.0		-0.17	CVKD
FHTX	0.0	-0.27	-0.03	0.0	0.01	0.18	0.0	-0.17		FHTX
	FWBI	SLRX	SABS	VCNX	GOVX	SNTI	ZIVO	CVKD	FHTX

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

GOVX	+ 0.9	SABS
SNTI	+ 0.51	SABS
SNTI	+ 0.5	SLRX
SABS	+ 0.48	SLRX
SNTI	+ 0.47	GOVX
GOVX	+ 0.45	SLRX

High negative correlations

CVKD	- 0.65	GOVX
CVKD	- 0.59	SABS
FHTX	- 0.27	SLRX
CVKD	- 0.2	SNTI
FHTX	- 0.17	CVKD
FHTX	- 0.03	SABS

Risk-Adjusted Indicators

There is a big difference between Titan Stock performing well and Titan Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Titan Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
FWBI	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
SLRX	7.96	0.61	0.06	0.13	7.36	(12.36)	15.57	(11.25)	161.82
SABS	5.31	(0.73)	0.00	(0.92)	0.00	0.00	11.72	(8.77)	71.75
VCNX	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
GOVX	3.12	(0.83)	0.00	2.17	0.00	0.00	6.45	(7.33)	21.24
SNTI	4.63	(0.36)	0.00	(0.47)	0.00	0.00	10.89	(11.96)	33.30
ZIVO	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CVKD	4.19	1.06	0.21	0.81	4.18	(5.26)	11.59	(8.49)	25.08
FHTX	3.69	(0.16)	0.00	(0.15)	0.00	0.00	9.05	(7.58)	26.22

Titan Pharmaceuticals Corporate Management

Brian Crowley	Senior Administration	Profile
Joe Schrei	Executive Operations	Profile
Weei Chay	Chief Officer	Profile
Marc MD	Ex Director	Profile
David Lazar	Principal Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC